Verona Pharma plc·4

Sep 3, 4:32 PM ET

ZACCARDELLI DAVID 4

4 · Verona Pharma plc · Filed Sep 3, 2025

Insider Transaction Report

Form 4
Period: 2025-08-29
ZACCARDELLI DAVID
DirectorPresident and CEO
Transactions
  • Gift

    Ordinary Shares

    2025-08-291,200,00012,176,144 total
Footnotes (2)
  • [F1]Reported securities are represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer.
  • [F2]Consists of (i) 2,375,000 Ordinary Shares underlying Restricted Share Units, each of which represents a contingent right to receive one (1) Ordinary Share of the Issuer (which are represented by 296,875 ADSs); and (ii) 9,801,144 Ordinary Shares underlying 1,225,143 ADSs.

Documents

1 file
  • 4
    tm2525084-3_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT